Cancer BiologybioRxivPreprint
Inhibition of EMT driver PTK6 enhances anti-tumor immune responses against triple-negative breast cancer
Ibuki Harada, Criseyda Martinez, Koichi Ito…·Hanna Yoko Irie
This study shows that inhibiting PTK6 in triple-negative breast cancer enhances anti-tumor immune responses by increasing CD8+ T and NK cells and reducing immunosuppressive cells.
DOI 10.1101/2025.01.11.632044